MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways

Sci Rep. 2016 Apr 18;6:23476. doi: 10.1038/srep23476.

Abstract

The MAP kinase-interacting kinases (MNK1 and MNK2) are non-essential enzymes which are activated by MAP kinases. They are implicated in controlling protein synthesis. Here we show that mice in which the expression of either MNK1 or MNK2 has been knocked out (KO) are protected against adverse effects of high-fat feeding, and in distinct ways. High-fat diet (HFD)-fed MNK2-KO show less weight gain than wild-type animals, and improved glucose tolerance, better insulin sensitivity and markedly diminished adipose tissue inflammation. This suggests MNK2 plays a role in adipogenesis and/or lipogenesis and in macrophage biology. MNK1-KO/HFD mice show better glucose tolerance and insulin sensitivity, but gain weight and show similar adipose inflammation to WT animals. These data suggest MNK1 participates in mediating HFD-induced insulin resistance. Our findings reveal distinct roles for the MNKs in a novel area of disease biology, metabolic dysfunction, and suggests they are potential new targets for managing metabolic disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes / metabolism
  • Adipocytes / pathology
  • Adipose Tissue / metabolism
  • Adipose Tissue / pathology
  • Animals
  • Cell Differentiation
  • Cell Line
  • Diet, High-Fat / adverse effects*
  • Glucose Tolerance Test
  • Inflammation / metabolism
  • Inflammation / pathology
  • Insulin Resistance*
  • Lipid Metabolism
  • Liver / metabolism
  • Macrophages / metabolism
  • Mice
  • Mice, Knockout
  • Organ Specificity
  • Protein-Serine-Threonine Kinases / genetics
  • Protein-Serine-Threonine Kinases / metabolism*

Substances

  • Mknk1 protein, mouse
  • Mknk2 protein, mouse
  • Protein-Serine-Threonine Kinases